Get v6.4 [Software]

posted by Artem Gusev  – Russia, Moscow, 2017-04-27 11:12 (3334 d 03:07 ago) – Posting: # 17274
Views: 8,109

(edited on 2017-04-27 11:32)

Dear Helmut!

Thank you for quick response.
I want to clarify one more point. I need to calculate additional parameter in ANOVA - Cohort factor.

Then in the case of a EMA Model Specification is:
sequence+subject(sequence)+period+treatment+cohort
Am I right?

And how Model Specification can be constructed for agencies recommending a mixed-effects model (FDA, Health Canada)?

Thank you!


Edit: This thread gets less software-related. I opened a new thread for answers. [Helmut]

Best Regards,
Artem

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
108 visitors (0 registered, 108 guests [including 28 identified bots]).
Forum time: 14:20 CEST (Europe/Vienna)

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking.    Stuart J. Pocock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5